OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
294140$3315.0056

Lemon Co Ltd

Specialty ChemicalsVerified

Lemon Co Ltd's capital structure is characterized by a high price-to-book ratio of 8.17 and a debt-to-equity ratio of 0.68, indicating moderate leverage. The company's liquidity position is weak, with a current ratio of 0.78 and negative free cash flow of -11,355,336,500 KRW. The negative operating cash flow of -7,705,124,200 KRW further highlights the company's cash flow challenges. Profitability metrics are severely negative, with a return on equity of -1.3214 and a return on assets of -0.4696. The company reported a net loss of 12,016,171,040 KRW and an operating loss of 12,105,086,460 KRW, indicating significant underperformance relative to industry norms. The gross profit of -1,096,938,960 KRW suggests cost overruns or pricing pressures. The company's revenue is concentrated in a single business segment focused on nanomembrane and nano fibers, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and regional economic fluctuations. Growth trajectory is negative, with no disclosed revenue growth in the current fiscal year. The company's capital expenditure of -10,293,500 KRW indicates minimal investment in expansion or modernization, which may hinder long-term competitiveness. Risk factors include liquidity constraints and a high debt burden, with long-term debt of 6,217,432,290 KRW. The risk assessment flags a negative net cash position after subtracting total debt, signaling potential refinancing challenges. Dilution risk is currently low, but the company's negative earnings and cash flow may necessitate future equity issuance. Recent events include a significant operating and net loss, which may impact investor confidence. No recent filings or transcripts disclose strategic changes or operational improvements.

30-day price · 294140-580.00 (-17.3%)
Low$2680.00High$4690.00Close$2770.00As of21 May, 00:00 UTC
Profile
CompanyLemon Co Ltd
Ticker294140.KQ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustrySpecialty Chemicals
AI analysis

Business. Lemon Co Ltd is a Korea-based company engaged in the manufacture and sale of nanomembrane and nano fibers used in electrical and electronic products, clothing, daily necessities, hygiene, and medical supplies.

Classification. Lemon Co Ltd is classified in the Basic Materials economic sector, Chemicals business sector, and Specialty Chemicals industry with 0.92 confidence.

Lemon Co Ltd's capital structure is characterized by a high price-to-book ratio of 8.17 and a debt-to-equity ratio of 0.68, indicating moderate leverage. The company's liquidity position is weak, with a current ratio of 0.78 and negative free cash flow of -11,355,336,500 KRW. The negative operating cash flow of -7,705,124,200 KRW further highlights the company's cash flow challenges. Profitability metrics are severely negative, with a return on equity of -1.3214 and a return on assets of -0.4696. The company reported a net loss of 12,016,171,040 KRW and an operating loss of 12,105,086,460 KRW, indicating significant underperformance relative to industry norms. The gross profit of -1,096,938,960 KRW suggests cost overruns or pricing pressures. The company's revenue is concentrated in a single business segment focused on nanomembrane and nano fibers, with no disclosed geographic diversification. This lack of diversification increases exposure to sector-specific risks and regional economic fluctuations. Growth trajectory is negative, with no disclosed revenue growth in the current fiscal year. The company's capital expenditure of -10,293,500 KRW indicates minimal investment in expansion or modernization, which may hinder long-term competitiveness. Risk factors include liquidity constraints and a high debt burden, with long-term debt of 6,217,432,290 KRW. The risk assessment flags a negative net cash position after subtracting total debt, signaling potential refinancing challenges. Dilution risk is currently low, but the company's negative earnings and cash flow may necessitate future equity issuance. Recent events include a significant operating and net loss, which may impact investor confidence. No recent filings or transcripts disclose strategic changes or operational improvements.
Key takeaways
  • Lemon Co Ltd is experiencing severe financial distress with negative operating and net income.
  • The company's liquidity position is weak, with a current ratio below 1 and negative free cash flow.
  • Profitability metrics are deeply negative, indicating significant operational challenges.
  • The company's business is concentrated in a single product line with no geographic diversification.
  • Capital expenditure is minimal, suggesting limited investment in growth or modernization.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyKRW
Revenue$7.46B
Gross profit-$1.10B
Operating income-$12.11B
Net income-$12.02B
R&D
SG&A
D&A
SBC
Operating cash flow-$7.71B
CapEx-$10.3M
Free cash flow-$11.36B
Total assets$25.59B
Total liabilities$16.49B
Total equity$9.09B
Cash & equivalents$3.62B
Long-term debt$6.22B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0
FY-1
FY-2
FY-3
FY-4
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0
FY-1
FY-2
FY-3
FY-4
PeriodOCFCapExFCFSBC
FY0
FY-1
FY-2
FY-3
FY-4
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodOCFCapExFCFSBC
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
Valuation
Market price$3315.00
Market cap$74.28B
Enterprise value$76.88B
P/E
Reported non-GAAP P/E
EV/Revenue10.3
EV/Op income
EV/OCF
P/B8.2
P/Tangible book8.2
Tangible book$9.09B
Net cash-$2.60B
Current ratio0.8
Debt/Equity0.7
ROA-47.0%
ROE-1.3%
Cash conversion64.0%
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric294140Activity
Op margin-162.3%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-161.1%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin-14.7%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-0.1%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity68.0%59.0% medp25 54.9% · p75 72.9%above median
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 03:06 UTC#7f67d4df
Market quoteclose KRW 3315.00 · shares 0.02B diluted
no public URL
2026-05-10 03:06 UTC#b809e667
Source: analysis-pipeline (hybrid)Generated: 2026-05-10 03:08 UTCJob: c0efedc6